Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy L Lash

Showing results (331-340 of 368) with videos related to

Pageof 37
Sort By:
Acta Oncologica (Stockholm, Sweden)|October 24, 2018
Expression of survivin does not appear to influence breast cancer recurrence riskLindsay J Collin, Deirdre P Cronin-Fenton, Thomas P Ahern, et al.
International Journal of Environmental Research and Public Health|January 31, 2014
Cancer cluster investigations: review of the past and proposals for the futureMichael Goodman, Judy S LaKind, Jerald A Fagliano, et al.
JCO Clinical Cancer Informatics|October 5, 2022
Automated Ascertainment of Typhlitis From the Electronic Health RecordTamara P Miller, Yimei Li, Aaron J Masino, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|September 14, 2024
Anthropometric Measures Among Children and Teens With Classic 46,XX Congenital Adrenal Hyperplasia in Relation to Improvements in Diagnosis and CareCourtney McCracken, Oumaima Kaabi, Mackenzie Crawford, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 14, 2011
Functional polymorphisms in UDP-glucuronosyl transferases and recurrence in tamoxifen-treated breast cancer survivorsThomas P Ahern, Mariann Christensen, Deirdre P Cronin-Fenton, et al.
Plos One|March 17, 2017
Apolipoprotein D expression does not predict breast cancer recurrence among tamoxifen-treated patientsDaniella Klebaner, Stephen Hamilton-Dutoit, Thomas Ahern, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 8, 2021
Changes in Size and Demographic Composition of Transgender and Gender Non-Binary Population Receiving Care at Integrated Health SystemsQi Zhang, Willi Rechler, Andrew Bradlyn, et al.
Breast Cancer Research : BCR|November 5, 2021
Hypoxia-inducible factor-1α expression and breast cancer recurrence in a Danish population-based case control studyLindsay J Collin, Maret L Maliniak, Deirdre P Cronin-Fenton, et al.
Journal of General Internal Medicine|December 7, 2007
Under utilization of surveillance mammography among older breast cancer survivorsTerry S Field, Chyke Doubeni, Matthew P Fox, et al.
Journal of the American College of Surgeons|December 25, 2007
Mortality impact of less-than-standard therapy in older breast cancer patientsMarianne Ulcickas Yood, Cynthia Owusu, Diana S M Buist, et al.
Pageof 37

Showing results (331-340 of 368) with videos related to

Sort By:
Pageof 37
Acta Oncologica (Stockholm, Sweden)|October 24, 2018
Expression of survivin does not appear to influence breast cancer recurrence riskLindsay J Collin, Deirdre P Cronin-Fenton, Thomas P Ahern, et al.
International Journal of Environmental Research and Public Health|January 31, 2014
Cancer cluster investigations: review of the past and proposals for the futureMichael Goodman, Judy S LaKind, Jerald A Fagliano, et al.
JCO Clinical Cancer Informatics|October 5, 2022
Automated Ascertainment of Typhlitis From the Electronic Health RecordTamara P Miller, Yimei Li, Aaron J Masino, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|September 14, 2024
Anthropometric Measures Among Children and Teens With Classic 46,XX Congenital Adrenal Hyperplasia in Relation to Improvements in Diagnosis and CareCourtney McCracken, Oumaima Kaabi, Mackenzie Crawford, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 14, 2011
Functional polymorphisms in UDP-glucuronosyl transferases and recurrence in tamoxifen-treated breast cancer survivorsThomas P Ahern, Mariann Christensen, Deirdre P Cronin-Fenton, et al.
Plos One|March 17, 2017
Apolipoprotein D expression does not predict breast cancer recurrence among tamoxifen-treated patientsDaniella Klebaner, Stephen Hamilton-Dutoit, Thomas Ahern, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 8, 2021
Changes in Size and Demographic Composition of Transgender and Gender Non-Binary Population Receiving Care at Integrated Health SystemsQi Zhang, Willi Rechler, Andrew Bradlyn, et al.
Breast Cancer Research : BCR|November 5, 2021
Hypoxia-inducible factor-1α expression and breast cancer recurrence in a Danish population-based case control studyLindsay J Collin, Maret L Maliniak, Deirdre P Cronin-Fenton, et al.
Journal of General Internal Medicine|December 7, 2007
Under utilization of surveillance mammography among older breast cancer survivorsTerry S Field, Chyke Doubeni, Matthew P Fox, et al.
Journal of the American College of Surgeons|December 25, 2007
Mortality impact of less-than-standard therapy in older breast cancer patientsMarianne Ulcickas Yood, Cynthia Owusu, Diana S M Buist, et al.
Pageof 37